- Trials with a EudraCT protocol (1,058)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1,058 result(s) found for: Cardiac Care.
Displaying page 1 of 53.
EudraCT Number: 2019-001995-12 | Sponsor Protocol Number: CCM1006 | Start Date*: 2019-09-27 | |||||||||||
Sponsor Name:CENTRO CARDIOLOGICO SPA FONDAZIONE MONZINO | |||||||||||||
Full Title: Cardiac Arrhythmia catheter ablation procedures guided by x-Ray imaging: N-Acetylcysteine Protection Against radiation induced Cellular damagE (CARAPACE Study). | |||||||||||||
Medical condition: Patients with Cardiac Arrhythmia who undergo catheter ablation procedures guided by x-Ray imaging | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000972-40 | Sponsor Protocol Number: MK-6621-055 | Start Date*: 2012-08-20 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A Multicentered, Randomized, Open-Label, Pragmatic Use Study Comparing Vernakalant Therapy to Amiodarone Therapy in Acute Management of Recent Onset Atrial Fibrillation. | |||||||||||||
Medical condition: Atrial Fibrilation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004773-13 | Sponsor Protocol Number: 00001 | Start Date*: 2018-02-27 | |||||||||||
Sponsor Name:Research Center for Emergency Medicine Department of Clinical Medicine Aarhus University | |||||||||||||
Full Title: Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest – A Randomized, Double-Blind, Placebo-Controlled Trial | |||||||||||||
Medical condition: The study will include patients with in-hospital cardiac arrest (IHCA). The study will test whether treatment with methylprednisolone and vasopressin added to standard care will improve survival fo... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-013066-31 | Sponsor Protocol Number: HSR-LEVO | Start Date*: 2009-07-31 | |||||||||||
Sponsor Name:FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR | |||||||||||||
Full Title: Levosimendan to reduce mortality in high risk cardiac surgery patients. A multicentre randomized controlled trial. | |||||||||||||
Medical condition: high risk cardiac surgery affected by low cardiac output syndrome (LCOs) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021263-33 | Sponsor Protocol Number: 3001101 | Start Date*: 2011-05-24 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Sykehuset i Vestfold HF | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: PERIOPERATIVE LEVOSIMENDAN INFUSION IN PATIENTS WITH HEART FAILURE UNDERGOING NON-CARDIAC SURGERY: A PROSPECTIVE, RANDOMISED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER STUDY | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Patients with serious cardiac failure scheduled for non-cardiac surgery | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: SE (Prematurely Ended) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000792-11 | Sponsor Protocol Number: | Start Date*: 2014-07-09 |
Sponsor Name:University of Warwick | ||
Full Title: Prehospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest | ||
Medical condition: Out of hospital cardiac arrest | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-002208-14 | Sponsor Protocol Number: Protocol v.1.2 30/08/04 | Start Date*: 2005-02-21 |
Sponsor Name:Cardiff and Vale NHS Trust | ||
Full Title: Duration of Amiodarone therapy required for new post cardiac surgery atrial fibrillation. | ||
Medical condition: Atrial fibrillation following cardiac surgery. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2013-004311-45 | Sponsor Protocol Number: 2013-PharmaCA-001 | Start Date*: 2014-03-25 | |||||||||||
Sponsor Name:Copenhagen University Hospital Rigshospitalet, Department of Cardiology B 2143 | |||||||||||||
Full Title: GLP-1 ANALOGS FOR NEUROPROTECTION AFTER OUT-OF-HOSPITAL CARDIAC ARREST, A RANDOMIZED CLINICAL TRIAL | |||||||||||||
Medical condition: We investigate the efficacy of commercially available GLP-1 analog for reducing post anoxic brain injury in patients who remain comatose after having been resuscitation from out of hospital cardiac... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000473-20 | Sponsor Protocol Number: CLCZ696B3402 | Start Date*: 2016-08-18 | |||||||||||
Sponsor Name:Novartis Pharma services AG | |||||||||||||
Full Title: A prospective evaluation of natriuretic peptide based referral of CHF patients in primary care | |||||||||||||
Medical condition: Chronic heart failure with reduced ejection fraction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HR (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001285-15 | Sponsor Protocol Number: KOIIM-2019-1 | Start Date*: 2019-06-28 |
Sponsor Name:University Medical Centre Ljubljana | ||
Full Title: Platelet inhibition with cangrelor in comatose survivors of out-of-hospital cardiac arrest undergoing primary percutaneous coronary intervention | ||
Medical condition: Comatose survivors of out-of-hospital cardiac arrest undergoing primary percutaneous coronary intervention | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-007287-42 | Sponsor Protocol Number: IVA-TCMD | Start Date*: 2009-04-17 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI PARMA | |||||||||||||
Full Title: Ivabradine in multislice CT: comparison with metoprolol in the reduction of motion artefacts and in the improvement of diagnostic care. | |||||||||||||
Medical condition: patients with coronary arteries desease, who need Tc multislice for diagnostic reasons | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016958-41 | Sponsor Protocol Number: FO002 | Start Date*: 2010-02-28 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA` GRANDA (A.O. DI RILIEVO NAZIONALE) | ||||||||||||||||||
Full Title: Early LEvosimendan Vs usual care in Advanced chronic hearT failurE | ||||||||||||||||||
Medical condition: Advanced chronic heart failure | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-003797-23 | Sponsor Protocol Number: KKS-305 | Start Date*: 2023-05-16 | ||||||||||||||||||||||||||
Sponsor Name:Philipps University Marburg | ||||||||||||||||||||||||||||
Full Title: Myeloperoxidase inhibition in patients with ischemic or non-ischemic cardiomyopathy and heart failure with reduced ejection fraction | ||||||||||||||||||||||||||||
Medical condition: Ischemic or non-ischemic cardiomyopathy and heart failure with reduced ejection fraction. Danke | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003088-87 | Sponsor Protocol Number: WWU20_0016 | Start Date*: 2021-11-22 | |||||||||||||||||||||||||||||||
Sponsor Name:Westfälische Wilhelms-Universität Münster | |||||||||||||||||||||||||||||||||
Full Title: Biomarker-guided implementation of angiotensin-II (AT-II) to reduce the occurrence of kidney damage after cardiac surgery | |||||||||||||||||||||||||||||||||
Medical condition: Cardiac surgical patients at high risk for AKI | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-005922-82 | Sponsor Protocol Number: IVIO1.3 | Start Date*: 2022-01-13 | |||||||||||
Sponsor Name:Prehospital Emergency Medical Services, Central Denmark Region | |||||||||||||
Full Title: Intravenous vs. Intraosseous Vascular Access During Out-of-Hospital Cardiac Arrest - A Randomized Clinical Trial | |||||||||||||
Medical condition: Out-of-hospital cardiac arrest (OHCA) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003053-24 | Sponsor Protocol Number: 614 | Start Date*: 2006-05-18 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: Prophylaxis with fenoldopam in cardiac surgery patients at high risk of postoperative renal failure | |||||||||||||
Medical condition: cardiac surgery patients at high risk of postoperative renal failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002366-23 | Sponsor Protocol Number: AD-V1-05252015 | Start Date*: 2015-10-13 |
Sponsor Name:Medical University of Vienna, Department of Anaesthesia, General Intensive Care and Pain Management | ||
Full Title: Goal-directed heart rate control during emergence from anesthesia using esmolol to attenuate myocardial injury in patients undergoing non-cardiac surgery | ||
Medical condition: myocardial damage | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-001809-50 | Sponsor Protocol Number: C3651011 | Start Date*: 2023-01-27 | |||||||||||
Sponsor Name:Pfizer Inc. | |||||||||||||
Full Title: A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, 4-ARM STUDY TO INVESTIGATE SYMPTOMS, FUNCTION, HEALTH-RELATED QUALITY OF LIFE AND SAFETY WITH REPEATED SUBCUTANEOUS ADMINISTRATION OF PONSEG... | |||||||||||||
Medical condition: Heart failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) DE (Trial now transitioned) HU (Trial now transitioned) PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002873-80 | Sponsor Protocol Number: AMILCA-DIFLU | Start Date*: 2020-01-14 |
Sponsor Name:FUNDACION JIMENEZ DIAZ HEALTH RESEARCH INSTITUTE | ||
Full Title: Unicentre, open, uncontrolled clinical trial to assess the morphological, biochemical and functional effects of Diflunisal treatment in patients with transthyretin cardiac amyloidosis | ||
Medical condition: transthyretin cardiac amyloidosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-000087-26 | Sponsor Protocol Number: 2019/09 | Start Date*: 2020-04-16 | |||||||||||||||||||||
Sponsor Name:CMC AMBROISE PARE | |||||||||||||||||||||||
Full Title: Time to transit Recovery After treatment with Naloxegol in cardiac Surgery Intensive care Trial | |||||||||||||||||||||||
Medical condition: ileus after cardiac surgery | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.